Kyphoplasty Market Expected to Reach $1.2 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Kyphoplasty Market," The kyphoplasty market was valued at $632.45 million in 2021, and is estimated to reach $1.2 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031.

Vertebral compression fracture (VCF) is a form of spinal disorder caused by the fracture of bones in the spinal cord as a result of osteoporosis, arthritis, or trauma. Kyphoplasty is one of the surgical options for treating this VCF. It commonly occurs in the vertebrae that have been weakened by osteoporosis or by other diseases. The fracture occurs when the bone has deteriorated to the point that it can no longer support the spine column in daily activities.

In Kyphoplasty, a needle is inserted into the spine bone via the skin. Real-time x-ray pictures help the doctor find the right spot in the lower back. A balloon is inserted into the bone through the needle; subsequently inflated and medical-grade bone cement is injected into that cavity. Bone cement, majorly consists of a liquid monomer and a copolymer powder, known as polymethylmethacrylate (PMMA). Hardening immediately, the cavity becomes stabilized by the substance. Thus, the height of the vertebrae is restored to prevent it from collapsing again. It is a generally safe procedure for restoring spinal height, correcting kyphosis deformity, and removing compression fracture discomfort.

Increase in the elderly population, surge in cases of osteoporosis & arthritis, and spine disorders are the major drivers of this market. Kyphoplasty is performed in cancer-damaged vertebrae, some spinal fractures, and also due to long-term steroid treatment or a metabolic disorder. In addition, it is a minimally invasive low risk procedure and has a short recovery time making it the safest treatment for VCF.  In addition, higher adoption rate of sedentary lifestyles, loss of physical activity especially among aging individuals, upsurge in accidents and trauma increases chances of having Kyphoplasty. Furthermore, innovations, development of advanced technologies, key strategies adopted by the key players and increasing awareness for spinal treatments kyphoplasty market trends. However, post-surgery complications such as cement leakage, are expected to hinder the kyphoplasty industry growth. Conversely, increase in spinal disease load and rise in healthcare expenditure are great opportunities for key players to invest during the forecast period, especially in the developing economies.

By product, the market is segmented into kyphoplasty systems and accessories. The accessories segment generated maximum revenue in 2021, owing to increase in the demand for bone cements, biopsy kits due to surge in the bone cancer cases. The kyphoplasty systems segment is expected to witness highest CAGR of 6.6% during the forecast period, owing to various developments and launch of products such as the balloon inflation devices and bone access devices.

Depending on indication, the market is divided into osteoporosis and others. The osteoporosis segment kyphoplasty market share in 2021, owing to increase in geriatric population, which is more prone to osteoporosis.  The others segment is expected to witness highest CAGR of 7.2% during the forecast period, owing to surge in the road accidents, sports injuries and cancer cases among the population.

Depending on end user, the market is divided into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment dominated the market in 2021, with $494.84 million, owing to increase in number of hospital admissions for vertebral compression fractures and accidental injuries to spinal cord. The ambulatory surgical centers segment is expected to witness highest kyphoplasty market growth during the forecast period, owing to surge in osteoporosis diagnosis and demand for ASCs, owing to its specific care and comfortable settings for elderly.

North America accounted for a majority of the global kyphoplasty market size in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in kyphoplasty techniques, integration of advanced devices and software processes in kyphoplasty devices, presence of key and robust hospital infrastructure in the region. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in geriatric population, development of healthcare infrastructure and increase in investments projects in the region.

KEY FINDINGS OF THE STUDY

• By product, the accessories segment was the highest contributor to the market in 2021, and is expected to continue this trend during the forecast period.
• By indication, osteoporosis segment was the highest contributor to the market in 2021, and is expected to continue this trend during the forecast period.
• Depending on end user, the hospital & clinics segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.
• Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.